Imgn stock price target
Witryna11 kwi 2024 · According to 18 analysts, the average rating for IMGN stock is "Buy." The 12-month stock price forecast is $12.58, which is an increase of 222.56% from the latest price. Price Target Witryna1 dzień temu · ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 28, 2024 to discuss its first quarter 2024 operating results. Management will also provide a brief update on …
Imgn stock price target
Did you know?
Witryna27 lut 2024 · With analysts defining $4.00-$22.00 as the low and high price targets, we arrive at a consensus price target of $12.10 for the trailing 12-month period. ... IMGN stock’s performance was -6.05% in the latest trading, and -22.13% in the past year, while Eli Lilly and Company (LLY) has traded -1.80% on the day and positioned 34.97% … WitrynaIMGN Stock 12 Months Forecast. $11.50. (183.25% Upside) Based on 5 Wall Street analysts offering 12 month price targets for ImmunoGen in the last 3 months. The …
Witryna14 kwi 2024 · ImmunoGen Inc. (IMGN) current stock price is $4.10. During the last trading session, the stock soared, reaching $4.165 after opening at $3.95. The … WitrynaImmunogen Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IMGN updated stock price target summary.
Witryna29 mar 2024 · ImmunoGen Stock Forecast 04-01-2024. Forecast target price for 04-01-2024: $ 3.76. Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.191%. Pessimistic target level: 3.71. Optimistic target level: 3.79. Witryna1 dzień temu · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for ImmunoGen (IMGN)
WitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian …
Witryna17 mar 2024 · The latest price target for . Immunogen (NASDAQ: IMGN) was reported by HC Wainwright & Co. on March 2, 2024.The analyst firm set a price target for $15.00 expecting IMGN to rise to within 12 ... sigbrit bachWitryna17 mar 2024 · The latest price target for . Immunogen (NASDAQ: IMGN) was reported by HC Wainwright & Co. on March 2, 2024.The analyst firm set a price target for … sig broadmeadowsWitrynaImmunogen (IMGN) Stock Key Data. Summary Additional Data Analysts Historical Quotes. Key Data. ... Consensus Price Target is the stock price analysts expect to … sig buckmaster any goodWitrynaAccording to . 6 Wall Street analysts that have issued a 1 year IMGN price target, the average IMGN price target is $12.83, with the highest IMGN stock price forecast at … sig buckmaster scopeWitryna9 kwi 2024 · 4 brokers have issued 1-year target prices for ImmunoGen's stock. Their IMGN share price forecasts range from $9.00 to $22.00. On average, they predict the … the premier league ohioWitryna6 kwi 2024 · Immunogen started at buy with $10 stock price target at Truist Nov. 21, 2024 at 7:42 a.m. ET by Tomi Kilgore ImmunoGen's stock is up 12% after the FDA … sig buckmaster 3-12x44 scopeWitryna5 kwi 2024 · Stock Price Forecast. According to 7 stock analysts, the average 12-month stock price forecast for NHWK stock is $ 11.73 , which predicts an increase of 1,203.19%. The lowest target is $ 8.08 and the highest is $ 16.28. On average, analysts rate NHWK stock as a buy. sig buckmaster 3x12x44 scope